Systematic Review and Meta-Analysis of Diagnostic Biomarkers for Pediatric Pneumonia
Open Access
- 2 July 2021
- journal article
- review article
- Published by Oxford University Press (OUP) in Journal of the Pediatric Infectious Diseases Society
- Vol. 10 (9) , 891-900
Abstract
Background: Pneumonia causes significant morbidity and mortality in children worldwide, especially in resource-poor settings. Accurate identification of bacterial etiology leads to timely antibiotic initiation, minimizing overuse, and development of resistance. Host biomarkers may improve diagnostic sensitivity and specificity. We assessed the ability of biomarkers to correctly identify bacterial pneumonia in children who present with respiratory distress. Methods: A librarian-directed search was conducted of MEDLINE, EMBASE, CENTRAL, Global Health, the World Health Organization International Clinical Trials Registry Platform, and ClinicalTrials.gov to May 2020 with no language restriction. Included studies compared a diagnostic biomarker in children with bacterial pneumonia to those with nonbacterial respiratory distress. Results: There were 31 observational studies of 23 different biomarkers. C-reactive protein (CRP), procalcitonin (PCT), white blood cell (WBC) count, and erythrocyte sedimentation rate (ESR) were the biomarkers with sufficient data for meta-analysis. Meta-analysis revealed that CRP and PCT best differentiated bacterial from viral pneumonia with CRP summary AUROC (area under the receiver operating characteristic curve) 0.71 (0.69-0.73), Youden index 53 mg/L, sensitivity 0.70 (0.68-0.78), and specificity 0.64 (0.58-0.68) and PCT summary AUROC 0.70 (0.67-0.74), Youden index 0.59 ng/mL, sensitivity 0.69 (0.65-0.77), and specificity 0.64 (0.60-0.68). WBC and ESR did not perform as well. Nineteen other inflammatory and immunologic biomarkers were identified including CRP/mean platelet value, neutrophil/leukocyte ratio, interleukin 6, and interferon-alpha, with sensitivities from 60% to 85% and specificities from 76% to 83%. Conclusion: CRP and PCT performed better than WBC and ESR but had suboptimal sensitivity. Some less well-studied novel biomarkers appear to have promise particularly in combination.Keywords
Funding Information
- Women & Children’s Health Research Institute Resident
This publication has 35 references indexed in Scilit:
- Causes of severe pneumonia requiring hospital admission in children without HIV infection from Africa and Asia: the PERCH multi-country case-control studyThe Lancet, 2019
- Global, regional, and national estimates of pneumonia morbidity and mortality in children younger than 5 years between 2000 and 2015: a systematic analysisThe Lancet Global Health, 2019
- Microscopic Analysis and Quality Assessment of Induced Sputum From Children With Pneumonia in the PERCH StudyClinical Infectious Diseases, 2017
- Limited Utility of Polymerase Chain Reaction in Induced Sputum Specimens for Determining the Causes of Childhood Pneumonia in Resource-Poor Settings: Findings From the Pneumonia Etiology Research for Child Health (PERCH) StudyClinical Infectious Diseases, 2017
- Global, regional, and national causes of under-5 mortality in 2000–15: an updated systematic analysis with implications for the Sustainable Development GoalsThe Lancet, 2016
- Accuracy of the Interpretation of Chest Radiographs for the Diagnosis of Paediatric PneumoniaPLOS ONE, 2014
- Specimen Collection for the Diagnosis of Pediatric PneumoniaClinical Infectious Diseases, 2012
- Paediatric radiology seen from Africa. Part I: providing diagnostic imaging to a young populationPediatric Radiology, 2011
- Adding fever to WHO criteria for diagnosing pneumonia enhances the ability to identify pneumonia cases among wheezing childrenArchives of Disease in Childhood, 2010
- Effect of pneumonia case management on mortality in neonates, infants, and preschool children: a meta-analysis of community-based trialsThe Lancet Infectious Diseases, 2003